Published in Biochemistry on February 21, 2011
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases. J Biol Chem (2011) 1.42
Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity. Mol Genet Metab (2012) 1.08
Native chemical ligation of thioamide-containing peptides: development and application to the synthesis of labeled α-synuclein for misfolding studies. J Am Chem Soc (2012) 1.04
Semisynthetic, site-specific ubiquitin modification of α-synuclein reveals differential effects on aggregation. J Am Chem Soc (2012) 0.95
The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17. Phys Chem Chem Phys (2011) 0.90
Identification of fibril-like tertiary contacts in soluble monomeric α-synuclein. Biophys J (2013) 0.83
Structural insights into amyloid oligomers of the Parkinson disease-related protein α-synuclein. J Biol Chem (2014) 0.80
Transmission electron microscopy characterization of fluorescently labelled amyloid β 1-40 and α-synuclein aggregates. BMC Biotechnol (2011) 0.80
Exploring the accessible conformations of N-terminal acetylated α-synuclein. FEBS Lett (2013) 0.79
A flash in the pan: dissecting dynamic amyloid intermediates using fluorescence. FEBS Lett (2013) 0.78
Taking a Bite Out of Amyloid: Mechanistic Insights into α-Synuclein Degradation by Cathepsin L. Biochemistry (2017) 0.75
Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu Rev Biochem (1997) 7.62
Structure and dynamics of micelle-bound human alpha-synuclein. J Biol Chem (2004) 3.87
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. Proc Natl Acad Sci U S A (2000) 3.86
The biochemistry of Parkinson's disease. Annu Rev Biochem (2005) 3.79
Molecular structure of amyloid fibrils: insights from solid-state NMR. Q Rev Biophys (2006) 3.54
Release of long-range tertiary interactions potentiates aggregation of natively unstructured alpha-synuclein. Proc Natl Acad Sci U S A (2005) 3.48
Molecular-level secondary structure, polymorphism, and dynamics of full-length alpha-synuclein fibrils studied by solid-state NMR. Proc Natl Acad Sci U S A (2005) 3.37
alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem (1999) 2.91
Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly. Proc Natl Acad Sci U S A (2008) 2.90
The fold of alpha-synuclein fibrils. Proc Natl Acad Sci U S A (2008) 2.82
Structural organization of alpha-synuclein fibrils studied by site-directed spin labeling. J Biol Chem (2003) 2.65
Investigation of alpha-synuclein fibril structure by site-directed spin labeling. J Biol Chem (2007) 2.30
Protein aggregation kinetics, mechanism, and curve-fitting: a review of the literature. Biochim Biophys Acta (2008) 2.29
Two-dimensional IR spectroscopy and isotope labeling defines the pathway of amyloid formation with residue-specific resolution. Proc Natl Acad Sci U S A (2009) 2.02
Impact of the acidic C-terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry (2004) 1.77
Alpha-synuclein binds large unilamellar vesicles as an extended helix. Biochemistry (2009) 1.73
Fibrils with parallel in-register structure constitute a major class of amyloid fibrils: molecular insights from electron paramagnetic resonance spectroscopy. Q Rev Biophys (2008) 1.67
Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci (2009) 1.66
Alpha-synuclein structures from fluorescence energy-transfer kinetics: implications for the role of the protein in Parkinson's disease. Proc Natl Acad Sci U S A (2004) 1.60
The mechanism of insulin action on islet amyloid polypeptide fiber formation. J Mol Biol (2004) 1.31
Characterization of oligomeric intermediates in alpha-synuclein fibrillation: FRET studies of Y125W/Y133F/Y136F alpha-synuclein. J Mol Biol (2005) 1.24
Characterization of oligomers during alpha-synuclein aggregation using intrinsic tryptophan fluorescence. Biochemistry (2006) 1.21
Determination of the free energy landscape of alpha-synuclein using spin label nuclear magnetic resonance measurements. J Am Chem Soc (2009) 1.21
Structural disorder in amyloid fibrils: its implication in dynamic interactions of proteins. FEBS J (2009) 1.19
Tertiary contact formation in alpha-synuclein probed by electron transfer. J Am Chem Soc (2005) 1.19
Amyloid fibril formation of alpha-synuclein is accelerated by preformed amyloid seeds of other proteins: implications for the mechanism of transmissible conformational diseases. J Biol Chem (2005) 1.14
Early aggregation steps in alpha-synuclein as measured by FCS and FRET: evidence for a contagious conformational change. Biophys J (2010) 1.14
Multiparametric fluorescence detection of early stages in the amyloid protein aggregation of pyrene-labeled alpha-synuclein. J Mol Biol (2008) 1.06
Detection of transient interchain interactions in the intrinsically disordered protein alpha-synuclein by NMR paramagnetic relaxation enhancement. J Am Chem Soc (2010) 1.06
Alteration of the alpha-synuclein folding landscape by a mutation related to Parkinson's disease. Angew Chem Int Ed Engl (2010) 1.06
Tryptophan probes at the alpha-synuclein and membrane interface. J Phys Chem B (2010) 1.05
Role of different regions of alpha-synuclein in the assembly of fibrils. Biochemistry (2007) 1.03
Tryptophan fluorescence reveals structural features of alpha-synuclein oligomers. J Mol Biol (2009) 0.94
Fluorescent ratiometric MFC probe sensitive to early stages of alpha-synuclein aggregation. J Am Chem Soc (2010) 0.93
Mechanisms and consequences of protein aggregation: the role of folding intermediates. Curr Protein Pept Sci (2009) 0.78
Performance of delayed-enhancement magnetic resonance imaging with gadoversetamide contrast for the detection and assessment of myocardial infarction: an international, multicenter, double-blinded, randomized trial. Circulation (2008) 2.62
Relationship of employee-reported work limitations to work productivity. Med Care (2003) 1.51
Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Arch Gen Psychiatry (2010) 1.43
The protein-folding speed limit: intrachain diffusion times set by electron-transfer rates in denatured Ru(NH3)5(His-33)-Zn-cytochrome c. Proc Natl Acad Sci U S A (2003) 1.43
Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases. J Biol Chem (2011) 1.42
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Pediatrics (2010) 1.40
Alpha-synuclein: stable compact and extended monomeric structures and pH dependence of dimer formation. J Am Soc Mass Spectrom (2004) 1.17
Biophysics of α-synuclein membrane interactions. Biochim Biophys Acta (2011) 1.08
Membrane-bound α-synuclein interacts with glucocerebrosidase and inhibits enzyme activity. Mol Genet Metab (2012) 1.08
Depth of α-synuclein in a bilayer determined by fluorescence, neutron reflectometry, and computation. Biophys J (2012) 1.06
Tryptophan probes at the alpha-synuclein and membrane interface. J Phys Chem B (2010) 1.05
Effects of pH on aggregation kinetics of the repeat domain of a functional amyloid, Pmel17. Proc Natl Acad Sci U S A (2010) 1.03
Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure. Am J Kidney Dis (2005) 1.00
Membrane remodeling by α-synuclein and effects on amyloid formation. J Am Chem Soc (2013) 0.99
Spermine binding to Parkinson's protein alpha-synuclein and its disease-related A30P and A53T mutants. J Phys Chem B (2008) 0.93
Site-specific collapse dynamics guide the formation of the cytochrome c' four-helix bundle. Proc Natl Acad Sci U S A (2006) 0.93
Alpha-synuclein structures probed by 5-fluorotryptophan fluorescence and 19F NMR spectroscopy. J Phys Chem B (2006) 0.92
Ferroxidase hephaestin's cell-autonomous role in the retinal pigment epithelium. Am J Pathol (2012) 0.91
The yin and yang of amyloid: insights from α-synuclein and repeat domain of Pmel17. Phys Chem Chem Phys (2011) 0.90
Identification of the minimal copper(II)-binding alpha-synuclein sequence. Inorg Chem (2009) 0.90
Equilibrium unfolding of the poly(glutamic acid)20 helix. Biopolymers (2007) 0.89
Cloning, heterologous expression, and characterization of recombinant class II cytochromes c from Rhodopseudomonas palustris. Biochim Biophys Acta (2003) 0.89
Evaluation of a cancer pain education module. Oncol Nurs Forum (2003) 0.88
Folding energy landscape of cytochrome cb562. Proc Natl Acad Sci U S A (2009) 0.87
Quantitative estimation of channeling from early glycolytic intermediates to CO in intact Escherichia coli. FEBS J (2005) 0.86
Probing fibril dissolution of the repeat domain of a functional amyloid, Pmel17, on the microscopic and residue level. Biochemistry (2011) 0.86
NMR structure of calmodulin complexed to an N-terminally acetylated α-synuclein peptide. Biochemistry (2013) 0.83
Effect of dioxygen on copper(II) binding to alpha-synuclein. J Inorg Biochem (2009) 0.82
Evidence for copper-dioxygen reactivity during alpha-synuclein fibril formation. J Am Chem Soc (2010) 0.81
Synchronous vs asynchronous chain motion in alpha-synuclein contact dynamics. J Phys Chem B (2009) 0.80
Saposin C protects glucocerebrosidase against α-synuclein inhibition. Biochemistry (2013) 0.80
Deuteration of Escherichia coli enzyme I(Ntr) alters its stability. Arch Biochem Biophys (2010) 0.80
Copper(II) enhances membrane-bound α-synuclein helix formation. Metallomics (2011) 0.79
Amyloid triangles, squares, and loops of apolipoprotein C-III. Biochemistry (2014) 0.79
Molecular origin of pH-dependent fibril formation of a functional amyloid. Chembiochem (2014) 0.79
Emerging insights into the mechanistic link between α-synuclein and glucocerebrosidase in Parkinson's disease. Biochem Soc Trans (2013) 0.78
School co-ethnicity and Hispanic parental involvement. Soc Sci Res (2012) 0.77
5-fluoro-D,L-tryptophan as a dual NMR and fluorescent probe of α-synuclein. Methods Mol Biol (2012) 0.76
Energy transfer ligands of the GluR2 ligand binding core. Biochemistry (2010) 0.75
Team approach with gynecologists taking the lead role in selecting patients for uterine artery embolization. W V Med J (2004) 0.75
Methyl-sulfonyl-methane (MSM)-induced acute angle closure. J Glaucoma (2015) 0.75